HK1059088A1 - Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor - Google Patents

Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor

Info

Publication number
HK1059088A1
HK1059088A1 HK04102013.5A HK04102013A HK1059088A1 HK 1059088 A1 HK1059088 A1 HK 1059088A1 HK 04102013 A HK04102013 A HK 04102013A HK 1059088 A1 HK1059088 A1 HK 1059088A1
Authority
HK
Hong Kong
Prior art keywords
verifiable
standardization
preparation
coriolus versicolor
oral absorbability
Prior art date
Application number
HK04102013.5A
Other languages
English (en)
Inventor
Albert H L Chow
Kevin K W Chu
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of HK1059088A1 publication Critical patent/HK1059088A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C12P19/08—Dextran
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
HK04102013.5A 2002-05-22 2004-03-18 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor HK1059088A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38333902P 2002-05-22 2002-05-22
US10/236,996 US7048932B2 (en) 2002-05-22 2002-09-06 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor

Publications (1)

Publication Number Publication Date
HK1059088A1 true HK1059088A1 (en) 2004-06-18

Family

ID=29552895

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102013.5A HK1059088A1 (en) 2002-05-22 2004-03-18 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor

Country Status (8)

Country Link
US (2) US7048932B2 (ja)
JP (1) JP2005526142A (ja)
AU (1) AU2003229257A1 (ja)
CA (1) CA2486483C (ja)
DE (1) DE10392697B4 (ja)
GB (1) GB2407321B (ja)
HK (1) HK1059088A1 (ja)
WO (1) WO2003097849A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091593A1 (en) * 2001-09-14 2003-05-15 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
EP1631496B1 (en) 2003-04-28 2014-02-26 Medical Instill Technologies, Inc. Container with valve assembly for filling and dispensing substances, and apparatus and method for filling
JP2005075740A (ja) * 2003-08-28 2005-03-24 Hajime Otani 免疫賦活化組成物、並びにそれが含まれた医薬品、動物薬、食品、飼料及び化粧品
ES2683919T3 (es) 2006-04-24 2018-09-28 Medical Instill Technologies, Inc. Dispositivo de liofilización que puede perforarse con una aguja y volverse a sellar, y método relacionado
US7854936B2 (en) 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
CA2812886C (en) * 2010-10-06 2020-04-14 Purapharm Company Limited Coriolus versicolor extracts, methods of preparation and uses thereof
CN109400686A (zh) * 2018-10-23 2019-03-01 西北农林科技大学 一种云芝β-葡聚糖肽的提取方法及其在肥胖或相关疾病中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051314A (en) * 1970-10-14 1977-09-27 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and method for producing same
JPS5290614A (en) * 1975-12-18 1977-07-30 Kureha Chem Ind Co Ltd Preparation of anti-tumor substance
PH14773A (en) * 1976-01-01 1981-12-09 Kureha Chemical Ind Co Ltd Protein-bound polysaccharides
JPS536412A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
US4851395A (en) * 1976-07-07 1989-07-25 Kureha Kagaku Kogyo Kabushiki Kausha Nitrogen-containing polysaccharide
JPS536413A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
JPS5315495A (en) * 1976-07-22 1978-02-13 Kureha Chem Ind Co Ltd Preparation of polysaccharides
JPS5329977A (en) * 1976-08-30 1978-03-20 Kureha Chem Ind Co Ltd Novel mono-nucleus mycelium of corilus species and its production
JPS5446830A (en) * 1977-09-16 1979-04-13 Kureha Chem Ind Co Ltd Pesticide for plant viral disease
JPS5461112A (en) * 1977-10-24 1979-05-17 Ono Pharmaceut Co Ltd Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
US4289888A (en) * 1978-08-11 1981-09-15 The Upjohn Company 2-Decarboxy-2-tetrazolyl-4-halo-5,9-epoxy-9-deoxy-PGF1 compounds
US4288505A (en) * 1980-10-24 1981-09-08 Ray-O-Vac Corporation High energy density solid state cell
JPS5932480B2 (ja) * 1981-02-10 1984-08-09 呉羽化学工業株式会社 新規な糖蛋白複合体
US4614733A (en) * 1981-12-31 1986-09-30 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides pharmaceutical compositions and the use thereof
DE3448152C2 (ja) * 1983-08-11 1989-11-02 Kureha Kagaku Kogyo K.K., Nihonbashi, Tokio/Tokyo, Jp
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
JPH0825896B2 (ja) * 1987-06-18 1996-03-13 呉羽化学工業株式会社 抗レトロウィルス剤
JPH0643336B2 (ja) * 1988-06-30 1994-06-08 呉羽化学工業株式会社 血管増殖抑制剤
CN1008537B (zh) * 1989-02-01 1990-06-27 上海师范大学 一种云芝糖肽(psp)的生产方法
US5374714A (en) * 1992-11-30 1994-12-20 Yang; Mable M. P. Purified coriolus versicolor polypeptide complex
AU3230393A (en) * 1992-11-30 1994-06-22 Department Of The Army Purified coriolus versicolor polypeptide complex
CA2156767A1 (en) * 1994-08-25 1996-02-26 Kenichi Matsunaga Binding agent for growth factor
JPH08208704A (ja) * 1995-02-06 1996-08-13 Kureha Chem Ind Co Ltd 新規な糖タンパク質複合体、その製造方法、並びに抗腫瘍剤、免疫調節剤及び増殖因子阻害剤
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質

Also Published As

Publication number Publication date
US20060073162A1 (en) 2006-04-06
AU2003229257A1 (en) 2003-12-02
US8158750B2 (en) 2012-04-17
JP2005526142A (ja) 2005-09-02
CA2486483C (en) 2014-04-01
US20030224014A1 (en) 2003-12-04
CA2486483A1 (en) 2003-11-27
GB2407321B (en) 2006-04-19
US7048932B2 (en) 2006-05-23
WO2003097849A1 (en) 2003-11-27
DE10392697T5 (de) 2005-11-17
GB2407321A (en) 2005-04-27
DE10392697B4 (de) 2010-07-29
GB0425752D0 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
WO2005051871A8 (en) Implantable sensors and implantable pumps and anti-scarring agents
EP1664746A4 (en) ANTIOXIDANT SENSOR, METHODS AND COMPOSITIONS THEREFOR
HK1083831A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
AU2003297742A8 (en) Integrated sensor and electronics package
MXPA03008775A (es) Productos y metodos para mejorar la higiene dental animal.
EP1451566A4 (en) PARTICLE IMPEDANCE SENSOR
AU2003214775A1 (en) Physiologically compatible cardiac assist device and method
EP1685094A4 (en) HYDROXAMATES CONNECTED TO ACYLUREE AND SULFONYLUREE
EP1730295A4 (en) SENSOR FOR DISEASES AND PROCEDURES IN FOODSTUFFS
GB0428391D0 (en) Connection and connection part
GB2407321B (en) Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003206170A1 (en) Organic-inorganic nanocomposite and preparation thereof
AU2003205568A1 (en) Extension and upsetting sensor
ZA200307846B (en) Latex and its preparation.
AU2003300772A1 (en) Preventive and therapeutic aids vaccines
GB2397444B (en) Electronics units and connections
GB0120009D0 (en) Cause and effect diagnosis
EP1578206A4 (en) SEPARATION OF MILK STOCKS AT THE YARD
AU2003226839A1 (en) Sausage and chocolate snack
AU2003294301A1 (en) Nerve root retractor and sucker
EG23600A (en) Treatment and prophylatic drug for malaria
AU2002952265A0 (en) Implantable sensor
AU2003245674A1 (en) Oral disease prevention and treatment
MXPA01013417A (es) Perfeccionamiento en envases desechables para alimentos diversos.

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 27 TO JOURNAL OF : [51] C07K, A61K, A61P

PE Patent expired

Effective date: 20230521